Evidence map›Paper›PMID 33442728›Full record

ArticleBioscience reports2021

ACE/ACE2 balance might be instrumental to explain the certain comorbidities leading to severe COVID-19 cases.

Sarbashri Bank, Subrata Kumar De, Biswabandhu Bankura, Smarajit Maiti, Madhusudan Das, Gausal A Khan

Open access · goldAbstract read
In one paragraph

Article in Bioscience reports, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers, 4 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed, 4 pooled it
3.3field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 4 syntheses or guidelines pooled it, 23 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Article
  6. Article
  7. Review
  8. Review
  9. Article
  10. TheInternational journal of molecular sciences · 2023
    Article
  11. Review
  12. Article
  13. Article
  14. Dipyridamole and adenosinergic pathway in Covid-19: a juice or holy grail.The Egyptian journal of medical human genetics · 2022
    Review
  15. Article
  16. Article
  17. Testosterone in COVID-19: An Adversary Bane or Comrade Boon.Frontiers in cellular and infection microbiology · 2021
    Review
  18. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 2 countries.

Sarbashri BankDepartment of Biochemistry, Vidyasagar University, Medinipur, India.
Subrata Kumar DeDepartment of Zoology, Vidyasagar University, Medinipur, India.
Biswabandhu BankuraDepartment of Zoology, University of Calcutta, Kolkata, India.
Smarajit MaitiOIST, Biochemistry and Biotechnology, Medinipur, India.
Madhusudan DasDepartment of Zoology, University of Calcutta, Kolkata, India.
Gausal A KhanDepartment of Physiology and Physiotherapy, CMNHS, Fiji School of Medicine, Fiji National University, Fiji.
University of Calcutta · INVidyasagar University · INFiji National University · FJ

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The outbreak of Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2) is a global catastrophe. The elderly and people with comorbidity are facing a serious complication of the disease. The entry and infection strategy of SARS-CoV-2 in a host cell is raised by an amazing way of angiotensin-converting enzyme (ACE) 2 (ACE2) receptor recognition and imbalance of ACE/ACE2 in various organs, especially in the lungs. Here it has been discussed the role of interferon and protease during the receptor recognition (begining of infection) and followed by the impact of cytokine and hypoxia in the context of the balance of ACE/ACE2. It has also very concisely delineated the biochemistry and mechanism of ACE/ACE2 balance in different stages of infection and its role in comorbidity.

Indexed as

Angiotensin-Converting Enzyme 2Angiotensin-Converting Enzyme InhibitorsAngiotensin Receptor AntagonistsComorbidityCOVID-19COVID-19 Drug TreatmentCytokinesHost-Pathogen InteractionsHumansPeptidyl-Dipeptidase ARenin-Angiotensin SystemSARS-CoV-2Virus InternalizationACE2 protein, humanACE protein, humanAngiotensin-Converting Enzyme 2Angiotensin-Converting Enzyme InhibitorsAngiotensin Receptor AntagonistsCytokinesPeptidyl-Dipeptidase AACE/ACE2ComorbidityHypoxiaSARS-CoV-2

Identifiers

PMID33442728
PMCPMC7856554
OpenAlexW3120888489

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.